Skip to content

Development of a Deep Learning-Based Multi-Center MRI Motion Artifact Correction System and Validation Study on Diagnostic Credibility

Development of a Deep Learning-Based Multi-Center MRI Motion Artifact Correction System and Validation Study on Diagnostic Credibility

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101403
Enrollment
Unknown
Registered
2025-04-24
Start date
2025-05-07
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head tumours/strokes, abdominal organ lesions, knee injuries, ankle trauma

Interventions

Internal Validation group :none
External Validation group :none

Sponsors

Changhai Hospital, The Navy Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Clinical Indications - Patients with clinically indicated MRI requisitions for targeted anatomical regions (disease group) - Healthy volunteers meeting study enrollment criteria with voluntary participation (health group) (2) Technical Feasibility - Capacity to complete dual-protocol MRI acquisitions: ? Standard clinical scanning protocol ? Motion-artifact induced scanning protocol (Use of FDA-approved artefact simulation devices) (3) Ethical Compliance - Signed dynamic electronic informed consent (DEIC) with blockchain-based audit trail(Deposit of evidence via blockchain) - Exclusion of concurrent enrollment in other imaging trials (Elution period >= 3 months)

Exclusion criteria

Exclusion criteria: (1) Safety Contraindications(excluded if any one of them is satisfied): - Absolute MRI contraindications (e.g., cardiac pacemakers/magnetic implants). - Pregnancy(admission permitted only with negative blood ß-hCG test). (2) Technical Limitations: - Body Mass Index (BMI) >=40 (due to scanning bore limitations). - Metallic implants in the target area (Artifact Reduction Score = 20). - Life expectancy < 6 months (for palliative care patients).

Design outcomes

Primary

MeasureTime frame
Consistency in Lesion Detection;Diagnostic Confidence Score;

Secondary

MeasureTime frame
Contrast-to-Noise Ratio;Signal-to-Noise Ratio;Peak Signal-to-Noise Ratio;Mean Structural Similarity Index Measure;

Countries

China

Contacts

Public ContactYun Bian

Changhai Hospital, The Navy Military Medical University

bianyun2012@foxmail.com+86 138 1635 7024

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026